Baseline T may provide valuable information about prognosis.

Prostate cancer screening saves many more lives than earlier studies suggested, research shows. The results from the longest-running European trial show one life saved for every six men diagnosed, a ...

MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics ...

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while mortality ​from dementia is on the rise, a large analysis has found.

Leerink Global Healthcare Conference 2026 March 11, 2026 9:20 AM EDTCompany ParticipantsJasper Van GrunsvenPeter Griffith - Executive ...

In people with type 2 diabetes in the world's richest countries, deaths from cardiovascular disease are declining while mortality from dementia is on the rise, a large analysis ...

Prostate cancer is one of the most common cancers among men. Many cases grow slowly and may never become life-threatening. Because of this, doctors often recommend a management approach called “active ...

Tracing the US military’s learning curve on fighting Iran’s drones: What to know Trump has one prescription for midterms. House Republicans have another Microsoft backs Anthropic, urging a judge to ...

An international team of scientists and clinicians has announced the launch of a new open-access 3D portal that allows users to explore intact human organs in unprecedented detail—from the whole organ ...

Men suffering from the disruptive symptoms of an enlarged prostate now have a new treatment option available at East Georgia Regional Medical Center. The hospital has introduced a state-of-the-art, ...

WVU Medicine St. Joseph’s Hospital and the Rotary Club of Buckhannon Upshur are offering affordable spring community blood screenings in Rock Cave (March 28) and Buckhannon (April 11, 18, 25 and May 2 ...

KEYNOTE-B15 compared perioperative enfortumab vedotin plus pembrolizumab against neoadjuvant cisplatin-based chemotherapy in cisplatin-eligible MIBC, using event-free survival as the primary endpoint.